Keeping an old friend under control: regulation of p53 stability

被引:92
作者
Kubbutat, MHG [1 ]
Vousden, KH [1 ]
机构
[1] NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Frederick, MD 21702 USA
来源
MOLECULAR MEDICINE TODAY | 1998年 / 4卷 / 06期
关键词
D O I
10.1016/S1357-4310(98)01260-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor protein p53 plays a pivotal role in protection against the development of cancer and is inactivated in many human malignancies. p53 is thought to prevent accumulation of genomic alterations by hindering cell proliferation in response to genotoxic stress, and two of the principal functions of p53 are the induction of cell-cycle arrest and the activation of apoptotic cell death. Because p53 is an extremely efficient inhibitor of cell growth, keeping p53 function under control in normal cells is critical. One of the principal mechanisms by which cells achieve this is by regulating the p53 protein level, although the ability of the protein to adopt active and latent forms and its cellular localization also contribute to the regulation of its function. Here, we summarize recently identified mechanisms that regulate the stability of the p53 protein and discuss the potentially immense clinical relevance of these observations in developing therapeutical approaches that aim to restore p53 function in human tumors.
引用
收藏
页码:250 / 256
页数:7
相关论文
共 50 条
[1]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[2]   p53 in signaling checkpoint arrest or apoptosis [J].
Bates, S ;
Vousden, KH .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (01) :12-18
[3]   Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells [J].
BeerRomero, P ;
Glass, S ;
Rolfe, M .
ONCOGENE, 1997, 14 (05) :595-602
[4]   Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo [J].
Bottger, A ;
Bottger, V ;
Sparks, A ;
Liu, WL ;
Howard, SF ;
Lane, DP .
CURRENT BIOLOGY, 1997, 7 (11) :860-869
[5]   CLONAL P53 MUTATION IN PRIMARY CERVICAL-CANCER - ASSOCIATION WITH HUMAN-PAPILLOMAVIRUS-NEGATIVE TUMORS [J].
CROOK, T ;
WREDE, D ;
TIDY, JA ;
MASON, WP ;
EVANS, DJ ;
VOUSDEN, KH .
LANCET, 1992, 339 (8801) :1070-1073
[6]   Participation of the human p53 3'UTR in translational repression and activation following gamma-irradiation [J].
Fu, LN ;
Benchimol, S .
EMBO JOURNAL, 1997, 16 (13) :4117-4125
[7]   Translational regulation of human p53 gene expression [J].
Fu, LN ;
Minden, MD ;
Benchimol, S .
EMBO JOURNAL, 1996, 15 (16) :4392-4401
[8]   On the involvement of calpains in the degradation of the tumor suppressor protein p53 [J].
Gonen, H ;
Shkedy, D ;
Barnoy, S ;
Kosower, NS ;
Ciechanover, A .
FEBS LETTERS, 1997, 406 (1-2) :17-22
[9]   Mdm2 promotes the rapid degradation of p53 [J].
Haupt, Y ;
Maya, R ;
Kazaz, A ;
Oren, M .
NATURE, 1997, 387 (6630) :296-299
[10]   MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection [J].
Henning, W ;
Rohaly, G ;
Kolzau, T ;
Knippschild, U ;
Maacke, H ;
Deppert, W .
JOURNAL OF VIROLOGY, 1997, 71 (10) :7609-7618